Evaluation of the Possible Protective Role of Adeno-Associated Virus Type 2 Infection in HPV-Associated Premalignant Disease of the Cervix
Authors:
- Cynthia C. van EeCECynthia C. van Ee
- Trivadi S. GanesanTGTrivadi S. Ganesan
- Andrew N. ShellingASAndrew N. Shelling
- 1 September 2000
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 78 (3) , 342-345
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adeno-Associated Virus Rep78 Inhibits Oncogenic Transformation of Primary Human Keratinocytes by a Human Papillomavirus Type 16-rasChimericGynecologic Oncology, 1997
- Growth properties of a human melanoma cell line are altered by adeno‐associated parvovirus type 2International Journal of Cancer, 1995
- Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78Cancer Letters, 1994
- Adeno-associated Virus Type 2: A Latent Life Cycle1994
- Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virusVirology, 1992
- Antineoplasic activity of parvovirusesJournal of Virological Methods, 1991
- Infection with adeno-associated virus type 5 inhibits mutagenicity of herpes simplex virus type 1 or 4-nitroquinoline-1-oxideMutation Research Letters, 1990
- The adeno-Associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirusVirology, 1989
- Adeno-Associated Viruses: An Update1987
- Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirusVirology, 1984